홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

R-Ginsenoside Rg3 → Ginsenoside Rg3

HRID 522486
노트
인쇄 미리보기

반응식

HRID 522486 반응식
[CH3:1][C:2]([CH3:55])=[CH:3][CH2:4][CH2:5][C@@:6]([OH:54])([C@@H:8]1[C@H:12]2[C@H:13]([OH:52])[CH2:14][C@@H:15]3[C@@:20]4([CH3:50])[CH2:21][CH2:22][C@H:23]([O:27][C@@H:28]5[O:33][C@H:32]([CH2:34][OH:35])[C@@H:31]([OH:36])[C@H:30]([OH:37])[C@H:29]5[O:38][C@@H:39]5[O:44][C@H:43]([CH2:45][OH:46])[C@@H:42]([OH:47])[C@H:41]([OH:48])[C@H:40]5[OH:49])[C:24]([CH3:26])([CH3:25])[C@@H:19]4[CH2:18][CH2:17][C@@:16]3([CH3:51])[C@:11]2([CH3:53])[CH2:10][CH2:9]1)[CH3:7]>O>[CH3:1][C:2]([CH3:55])=[CH:3][CH2:4][CH2:5][C@:6]([OH:54])([C@@H:8]1[C@H:12]2[C@H:13]([OH:52])[CH2:14][C@@H:15]3[C@@:20]4([CH3:50])[CH2:21][CH2:22][C@H:23]([O:27][C@@H:28]5[O:33][C@H:32]([CH2:34][OH:35])[C@@H:31]([OH:36])[C@H:30]([OH:37])[C@H:29]5[O:38][C@@H:39]5[O:44][C@H:43]([CH2:45][OH:46])[C@@H:42]([OH:47])[C@H:41]([OH:48])[C@H:40]5[OH:49])[C:24]([CH3:25])([CH3:26])[C@@H:19]4[CH2:18][CH2:17][C@@:16]3([CH3:51])[C@:11]2([CH3:53])[CH2:10][CH2:9]1)[CH3:7]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

3

반응물 1

HCID 46887680R-Ginsenoside Rg3

생성물 1

HCID 9918693Ginsenoside Rg3

시약·촉매·용매 1

HCID 962Water용매2회

실험 절차

Take 100 ml of 20(R)-ginsenoside Rg3 composition solution obtained from Operation Example 1, add water for injection to 1000 ml, and add 0.1 grams of injection grade active carbon and mix to uniformity. Leave it at 80° C. for 30 minutes, remove the pyrogen with 0.45 μm micropore membrane filtering, sterilize with a 0.22 μm micropore filter membrane under sterile conditions, dispense into a 10 ml sterile antibiotics tube vial under sterile conditions, and the quantity of each tube vial is 4.5˜4.9 ml:5 mg. After the dispensed, the antibiotics tube vials are half-corked, they are transferred onto the plate of lyophilizer (LYO-5, manufactured in Shanghai). Close the door of the lyophilizer, turn on the lyophilizer and first freeze to below −40° C. and keep for 4 hours, and then start vacuum drying as following program for sublimation: −45˜−30° C. for 4 hours, −30˜−20° C. for 4 hours, −20˜−15° C. for 2 hours. Finally, dry for 4 hours at 15˜30° C., and the lyophilization process is complete. After lyophilization, the corks are fully plugged and aluminum covers are pressed on with a sealing machine. Sample some sample for testing. Pack the qualified tube vials. 1000 tube vials of lyophilized powder for injection (3.1 mg Rg3/vial) are obtained. The above-mentioned procedures can be carried out for Example 2-40 to produce water-soluble powder of ginsenoside Rg3.

후처리

  1. additionadd 0.1 grams of injection grade active carbon
  2. additionmix to uniformity
  3. customLeave it at 80° C. for 30 minutes
  4. customremove the pyrogen with 0.45 μm micropore membrane
  5. filtrationfiltering
  6. filtrationsterilize with a 0.22 μm micropore filter membrane under sterile conditions, dispense into a 10 ml sterile antibiotics tube vial under sterile conditions
  7. customthe quantity of each tube vial is
  8. customClose the door of the lyophilizer, turn on the lyophilizer and first freeze to below −40° C.
  9. customdrying
  10. wait−45˜−30° C. for 4 hours
  11. wait−30˜−20° C. for 4 hours
  12. wait−20˜−15° C. for 2 hours
  13. customFinally, dry for 4 hours at 15˜30° C.
  14. custom1000 tube vials of lyophilized powder for injection (3.1 mg Rg3/vial) are obtained

출처 및 근거

ORD 기록
ord-dc81a58377fb450c814925f3307cff37
출처 데이터셋
uspto-grants-2016_05
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09333215B2

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트